Bibliografia UJ CM

1/10
Irene Dogliotti, Cristina Jimenez, Marzia Varettoni, Dipti Talaulikar, Tina Bagratuni, Martina Ferrante, Jose Perez, Daniela Drandi, Noemi Puig, Milena Gilestro, Maria Garcia-Alvarez, Roger Owen, Wojciech Jurczak, Alessandra Tedeschi, Veronique Leblond, Efstathios Kastritis, Marie Jose Kersten, Shirley D'Sa, Michal Kascak, Wolfgang Willenbacher, Aldo M. Roccaro, Stephanie Poulain, Pierre Morel, Charalampia Kyriakou, Falko Fend, Josephine M.I. Vos, Meletios A. Dimopoulos, Christian Buske, Simone Ferrero, Ramon Garcia-Sanz.
Diagnostics in Waldenström's macroglobulinemia : a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
Leukemia
2023 : Vol. 37, nr 2, s. 388-395, bibliogr. 60 poz.
Autor korespondencyjny: Cristina Jimenez
Online First 2022-11-26
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0887-6924
e-ISSN: 1476-5551
AZ
WYT
AIF
IF: 11.400
Adres url:
Streszczenie w PubMed:
2/10
Christian Buske, Wojciech Jurczak, Joe-Elie Salem, Meletios A. Dimopoulos.
Managing Waldenström's macroglobulinemia with BTK inhibitors
Leukemia
2023 : Vol. 37, nr 1, s. 35-46, il., bibliogr. 96 poz.
Autor korespondencyjny: Christian Buske
Online First 2022-11-19
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0887-6924
e-ISSN: 1476-5551
AZ
POG
AIF
IF: 11.400
Adres url:
Streszczenie w PubMed:
3/10
Meletios A. Dimopoulos, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Bjorn E. Wahlin, Ramon Garcia-Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernandez de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Steven P. Treon, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Heather Allewelt, Sheel Patel, Aileen Cohen, Constantine S. Tam.
Zanubrutinib versus ibrutinib in symptomatic Waldenström macroglobulinemia : final analysis from the randomized phase III ASPEN study
Journal of Clinical Oncology
2023, il., bibliogr. 16 poz., abstr.
Autor korespondencyjny: Meletios A. Dimopoulos
Online First 2023-07-21
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
XXX
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
4/10
Larry W. Kwak, Juan-Manuel Sancho, Seok-Goo Cho, Hideyuki Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim, Tobias Menne, Jose Mariz, Nikolai Ilyin, Wojciech Jurczak, Aurelio Lopez Martinez, Olga Samoilova, Edvard Zhavrid, Eduardo Yanez Ruiz, Marek Trneny, Leslie Popplewell, Michinori Ogura, Won-Seog Kim, Sang Joon Lee, Sung Hyun Kim, Keum Young Ahn, Christian Buske.
Efficacy and safety of CT-P10 versus rituximab in untreated low-tumor-burden follicular lymphoma : final results of a randomized phase III study.
Clinical Lymphoma, Myeloma and Leukemia
2022 : Vol. 22, nr 2, s. 89-97, il., bibliogr. 24 poz., abstr.
Autor korespondencyjny: Christian Buske.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 2152-2650
e-ISSN: 2152-2669
AZ
ORG
AIF
IF: 2.700
Adres url:
Streszczenie w PubMed:
5/10
Christian Buske, Wojciech Jurczak, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, José-Ángel Hernández-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajnish Nagarkar, Larry Kwak, Won-Seog Kim, SangJoon Lee, SungHyun Kim, KeumYoung Ahn, Michinori Ogura.
Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma : a randomized phase 3 study.
Blood Advances
2021 : Vol. 5, nr 17, s. 3354-3361, il., bibliogr. 20 poz.
Autor korespondencyjny: Michinori Ogura.
p-ISSN: 2473-9529
e-ISSN: 2473-9537
AZ
ORG
AIF
IF: 7.642
Adres url:
Streszczenie w PubMed:
6/10
Constantine S. Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton Marlton, Björn E. Wahlin, Ramon Garcia Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernandez de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Sunhee Ro, Aileen Cohen, Jane Huang, Meletios Dimopoulos.
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia : the ASPEN study.
Blood
2020 : Vol. 136, nr 18, s. 2038-2050, il., bibliogr. 39 poz., abstr.
Auto korespondencyjny: Constantine S. Tam.
p-ISSN: 0006-4971
AZ
ORG
AIF
IF: 22.113
Adres url:
Streszczenie w PubMed:
7/10
Wojciech Jurczak, Monika Długosz-Danecka, Christian Buske.
Rituximab biosimilars for lymphoma in Europe.
Expert Opinion on Biological Therapy
2019 : Vol. 19, nr 10, s. 1045-1056, il., bibliogr. 118 poz., abstr.
Autor korespondencyjny: Wojciech Jurczak.
p-ISSN: 1471-2598
e-ISSN: 1744-7682
AZ
POG
AIF
IF: 3.224
Adres url:
Streszczenie w PubMed:
8/10
Michinori Ogura, Juan Manuel Sancho, Seok-Goo Cho, H. Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim, Anne Lennard, Jose Mariz, Nikolai Ilyin, Wojciech Jurczak, Aurelio Lopez Martinez, Olga Samoilova, Edvard Zharvid, Eduardo Yanez Ruiz, Marek Trneny, Leslie Popplewall, Bertrand Coiffier, Christian Buske, Won-Seog Kim, Sang Joon Lee, Sung Young Lee, Jun Ju Bae, Larry W. Kwak.
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial.
Lancet. Haematology
2018 : Vol. 5, nr 11, s. e543-e553, il., bibliogr.
Autor korespondencyjny: Larry W. Kwak.
p-ISSN: 2352-3026
AZ
ORG
AIF
IF: 11.990
Adres url:
Streszczenie w PubMed:
DOI:
9/10
Won Seog Kim, Christian Buske, Michinori Ogura, Wojciech Jurczak, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, José-Ángel Hernández-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajinish Nagarkar, Dzhelil Osmanov, Larry W. Kwak, Sang Joon Lee, Sung Young Lee, Yun Ju Bae, Bertrand Coiffier.
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial.
Lancet. Haematology
2017 : Vol. 4, nr 8, s. e362-e373
Autor korespondencyjny: Bertrand Coiffier.
p-ISSN: 2352-3026
AZ
ORG
AIF
IF: 10.698
Adres url:
Streszczenie w PubMed:
DOI:
10/10
Wojciech Jurczak, Pier Luigi Zinzani, Gianluca Gaidano, Andre Goy, Mariano Provencio, Zsolt Nagy, Tadeusz Robak, Kami J. Maddocks, Christian Buske, Sumeet Ambarkhane, Mark Winderlich, Maren Dirnberger-Hertweck, Jan Endell, Kristie A. Blum.
Single-Agent MOR208 in Relapsed or Refractory (R-R) Non-Hodgkin's Lymphoma (NHL): Results from Diffuse Large B-Cell Lymphoma (DLBCL) and Indolent NHL Subgroups of a Phase IIa Study.
Blood
2016 : Vol. 128, nr 22, s. 623
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971
SZZ
SIF
Adres url:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ